A prospective randomized, double‐blinded clinical study evaluating the efficacy and safety of bupivacaine versus morphine‐bupivacaine in caudal epidurals in cats with urethral obstruction

summary of:
A prospective randomized, double‐blinded clinical study evaluating the efficacy and safety of bupivacaine versus morphine‐bupivacaine in caudal epidurals in cats with urethral obstruction
Author(s):
C.L.Pratt, A. Balakrishnan, E. McGowan, K.J. Drobatz and E.L Reineke
Published in:
Date:
March/April 2020
DOI:
Type of access:

Requires membership/payment

This article can be accessed via RCVS Knowledge Library Membership (click here).

Find out more about the benefits of our membership.
In our edition of: Jun 2020
In our categories of: small animals

our summary:

Pratt, C. L.et al. (2020) A prospective randomized, double‐blinded clinical study evaluating the efficacy and safety of bupivacaine versus morphine‐bupivacaine in caudal epidurals in cats with urethral obstruction. Journal of Veterinary Emergency and Critical Care, 30 (2), pp. 170-178

The aim of this prospective, double-blinded, randomised, sham-controlled study was to investigate whether the use of the caudal epidural technique in cats with urethral obstruction (UO) facilitates the process of urinary catheter placement and provides longer-term analgesia during hospitalisation.

The study was carried out at a single veterinary hospital in the United States; male cats treated for UO between February 2013 and January 2015 were eligible for inclusion. Cats were randomised into blocks of 20 to receive either a: bupivacaine caudal epidural (BUP); (2) morphine‐bupivacaine epidural (BUP/MOR), or a sham epidural (SHAM). Investigators were blinded to which epidural group the cat was in; cats in the sham group did not have an epidural performed but all other procedures (clipping, adhesive bandage etc.) were the same. An empty vial was included in the study kit to ensure the blinding of the technicians performing the epidural efficacy and pain assessments.

The study recorded the time to perform the epidural, time to place the urinary catheter and the time from epidural administration until breakthrough pain score was reached and rescue analgesia administered. Pain scoring was performed every two hours following urinary catheter placement. The success of the epidural was assessed by way of tail and perineal responses to stimuli 10 minutes after drug administration.

Eighty-eight male cats were included in the study as follows: 30 cats – bupivacaine only epidural (BUP); 28 cats – bupivacaine-morphine epidural (BUP/MOR); and 30 cats – sham epidural (SHAM).

Results showed 34% of cats had one epidural attempt, for the remaining 66% the epidural was successful on the second attempt. The median time to perform epidural was two minutes for both the first and second attempts. Forty-one cats, including 21 BUP and 20 MOR/BUP, had a successful epidural based on loss of either/both perineal or tail response. 13 cats (6 BUP and 7 MOR/BUP) showed no change in either perineal or tail response following epidural. There was no significant difference in the median time for urinary catheter placement in the SHAM cats (3 minutes), or epidural cats (2 minutes).

Reduction of pain was significantly longer in the BUP and MOR/BUP cats (8 hours and 10 hours respectively) compared to SHAM cats (2 hours). There was no significant difference in the median time to rescue analgesia between the BUP and MOR/BUP cats, but it was significantly longer in the BUP and MOR/BUP cats (both 10 hours) compared to SHAM cats (4 hours). There were no complications related to the epidural.

One limitation of the study was the use of a multidimensional pain scoring system that has not been validated for use in cats with UO.

Take Home

Feline urethral obstruction is a painful and life-threatening emergency commonly presented in primary practice. This study provides some evidence of the benefits of caudal epidurals to facilitate urinary catheterisation and in the management of post-operative pain in cats with UO.

Join the discussion

We encourage discussion on all material highlighted in each edition of inFOCUS. Use the button below to join the conversation on Twitter and include your comment in the feed for this issue.

Twitter feed is not available at the moment.
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.